159 related articles for article (PubMed ID: 31776569)
1. Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion.
Martin GE; Pace M; Shearer FM; Zilber E; Hurst J; Meyerowitz J; Thornhill JP; Lwanga J; Brown H; Robinson N; Hopkins E; Olejniczak N; Nwokolo N; Fox J; Fidler S; Willberg CB; Frater J
J Infect Dis; 2020 Mar; 221(7):1135-1145. PubMed ID: 31776569
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.
Jain V; Hartogensis W; Bacchetti P; Hunt PW; Hatano H; Sinclair E; Epling L; Lee TH; Busch MP; McCune JM; Pilcher CD; Hecht FM; Deeks SG
J Infect Dis; 2013 Oct; 208(8):1202-11. PubMed ID: 23852127
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
[TBL] [Abstract][Full Text] [Related]
4. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.
Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK;
AIDS; 2015 May; 29(8):911-9. PubMed ID: 25730509
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy.
Martin GE; Sen DR; Pace M; Robinson N; Meyerowitz J; Adland E; Thornhill JP; Jones M; Ogbe A; Parolini L; Olejniczak N; Zacharopoulou P; Brown H; Willberg CB; Nwokolo N; Fox J; Fidler S; Haining WN; Frater J
Front Immunol; 2021; 12():647688. PubMed ID: 34149690
[TBL] [Abstract][Full Text] [Related]
6. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H
J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282
[TBL] [Abstract][Full Text] [Related]
7. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
8. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
[TBL] [Abstract][Full Text] [Related]
9. Virtual memory CD8+ T cells restrain the viral reservoir in HIV-1-infected patients with antiretroviral therapy through derepressing KIR-mediated inhibition.
Jin JH; Huang HH; Zhou MJ; Li J; Hu W; Huang L; Xu Z; Tu B; Yang G; Shi M; Jiao YM; Fan X; Song JW; Zhang JY; Zhang C; Wang FS
Cell Mol Immunol; 2020 Dec; 17(12):1257-1265. PubMed ID: 32210395
[TBL] [Abstract][Full Text] [Related]
10. Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.
Cao W; Mehraj V; Trottier B; Baril JG; Leblanc R; Lebouche B; Cox J; Tremblay C; Lu W; Singer J; Li T; Routy JP; ; Vézina S; Charest L; Milne M; Huchet E; Lavoie S; Friedman J; Duchastel M; Villielm F; Côté P; Potter M; Lessard B; Charron MA; Dufresne S; Turgeon ME; Rouleau D; Labrecque L; Fortin C; de Pokomandy A; Hal-Gagné V; Munoz M; Deligne B; Martel-Laferrière V; Gilmore N; Fletcher M; Szabo J
Clin Infect Dis; 2016 Jan; 62(2):250-257. PubMed ID: 26349551
[TBL] [Abstract][Full Text] [Related]
11. Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8
Veel E; Westera L; van Gent R; Bont L; Otto S; Ruijsink B; Rabouw HH; Mudrikova T; Wensing A; Hoepelman AIM; Borghans JAM; Tesselaar K
Front Immunol; 2018; 9():572. PubMed ID: 29619031
[TBL] [Abstract][Full Text] [Related]
12. Partial recovery of senescence and differentiation disturbances in CD8
Eberhard JM; Ahmad F; Hong HS; Bhatnagar N; Keudel P; Schulze Zur Wiesch J; Schmidt RE; Meyer-Olson D
Clin Exp Immunol; 2016 Nov; 186(2):227-238. PubMed ID: 27377704
[TBL] [Abstract][Full Text] [Related]
13. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection.
Buggert M; Tauriainen J; Yamamoto T; Frederiksen J; Ivarsson MA; Michaëlsson J; Lund O; Hejdeman B; Jansson M; Sönnerborg A; Koup RA; Betts MR; Karlsson AC
PLoS Pathog; 2014 Jul; 10(7):e1004251. PubMed ID: 25032686
[TBL] [Abstract][Full Text] [Related]
14. Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy.
Chen J; Xun J; Yang J; Ji Y; Liu L; Qi T; Wang Z; Zhang R; Shen Y; Ponte R; Mehraj V; Routy JP; Lu H
Clin Infect Dis; 2019 Apr; 68(8):1274-1281. PubMed ID: 30107503
[TBL] [Abstract][Full Text] [Related]
15. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
[TBL] [Abstract][Full Text] [Related]
16. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA
J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M;
Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544
[TBL] [Abstract][Full Text] [Related]
18. Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression.
Tanko RF; Soares AP; Masson L; Garrett NJ; Samsunder N; Abdool Karim Q; Abdool Karim SS; Riou C; Burgers WA
Clin Immunol; 2018 Oct; 195():127-138. PubMed ID: 29883708
[TBL] [Abstract][Full Text] [Related]
19. T-cell subset differentiation and antibody responses following antiretroviral therapy during simian immunodeficiency virus infection.
Bhattacharyya M; Whitney JB; Seaman M; Barouch DH; Penaloza-MacMaster P
Immunology; 2018 Dec; 155(4):458-466. PubMed ID: 30014618
[TBL] [Abstract][Full Text] [Related]
20. HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy.
Wang N; Li Y; Han Y; Xie J; Li T
J Med Virol; 2017 Jun; 89(6):982-988. PubMed ID: 27791274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
